Alliance Pharma Plc
| London Stock Exchange: APH
Alliance Pharma Plc operates as a pharmaceutical company. It engages in the in the manufacturing, marketing, storage, logistics and sales forces are controlled by Alliance but outsourced to leading specialist organisations in these fields. Alliance's principal activities are the acquisition and licensing of mature pharmaceutical products and the marketing of those products. Its key products includes, Deltacortril, Nu-Seals, Forceval Capsules, Immucyst and Hydromol. The company was founded by John Dawson in 1996 and is headquartered in Chippenham, the United Kingdom.